RPTOR and cardiovascular disorder: Moreover, PKA may also inhibit mTORC1 activity by phosphorylating the upstream regulatory factors of mTORC1, Raptor and TSC2, improving various age‐related diseases such as cardiovascular diseases, neurodegenerative diseases and metabolic diseases [49].